PDL BioPharma, Inc. (NASDAQ:PDLI)
A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
As with most biotechs, this is a risky investment but the reward potential is high. Not a big fan of the long-term potential of humanized mAbs, but the pipeline is strong and the price seems attractive for the company's potential.
Not a one trick pony, and strong cash position should keep the business strong for at least another 2 years.
I see this as a good 2-4 year investment: once it hits stride, look to sell because its technology will be antiquated.
Recs
Got pounded for an earnings miss though they don't really have earnings yet. I like what I hear from others here and tend to agree. They should be profitable soon and should really rise from here.
Recs
I think the stock is highly undervalued at present and the company has a great pipeline of drugs.
Recs
Great pipeline of various drugs. Long term hold.
Recs
Picked by Databasebob
Recs
I've got this in real life with a cost basis of $14. Rode it up to $30 and back down to $20. Charly recommended, with a solid pipeline.
Recs
If Charly likes it, I like it
Recs
On saaale!
Recs
This has been a great performer so far, and its recent, unfounded "market correction" make this an especially good time to get in.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 121 - 129 of 129 : « Previous 2 3 4 5 6 7